Montgomery County is well known for many transformative firsts in life sciences. First to sequence the human genome; first gene therapy for sickle cell, first cell therapy for COVID-19 — and that’s just the start.* Montgomery County is an epicenter for translating knowledge into life-changing treatment and cures, with gene and cell therapies representing some of the most promising advancements in human health.
The Life Sciences Advisory Board added three new members, Ellington West of Sonavi Labs, Michael Weingarten of the National Cancer Institute, and GlaxoSmithKline’s KaShauna G. Rohlehr.
2022 ISPE Mid-Atlantic Science & Technology Showcase Brings the Local Life Science Community Back Together
After 2 (long) years, the widely-popular ISPE Mid-Atlantic Science & Technology (MAST) Showcase was back in person, with excitement and energy filling the rooms as professionals from across the BioHealth Capital Region and beyond gathered at the Turf Valley Resort in Ellicott City, MD.
The Center for Breakthrough Medicines has expanded its leadership team with the hiring of former GlaxoSmithKline and Johnson & Johnson executive John Lee.
To further our commitment to increase the number of diverse Philadelphia students entering STEM careers by 2030, GSK will support at least $1 million in grant funds each year to nonprofit organizations working to address inequity in STEM education and career pathways.
Life sciences talent teams have risen to pandemic challenges to create an entirely new hiring process and ecosystem in short order. This new process seemed strange at first, even awkward and alien, but once the dust settled an innovative new approach spearheaded by a move to remote methods emerged, yielding greater efficiencies.
Much like commercial real estate and office space design will never be the same, the talent acquisition game has irrevocably changed. And some would say this change is for the better.
Let’s take a look back on some of these pandemic-inspired changes to talent acquisition that have taken root in response to the pandemic.
Azita Adli is a passionate, innovative, and quality-minded professional with 10+ years of experience within the pharmaceutical industry. Azita has held roles within production, investigation, quality systems, and central quality throughout her career, supporting sites within GlaxoSmithKline’s (GSK’s) Pharmaceutical Supply Chain.
5 Questions with KaShauna G. Rohlehr, Associate Director of Alliance, Program, and Project Management, GlaxoSmithKline
KaShauna G. Rohlehr is a highly motivated, results-driven technical and project management professional with 16+ years of experience in the pharmaceutical industry. Over her career, she has held positions within production, quality, technical, and supply chain organizations supporting vaccines and biopharmaceuticals manufacturing. She has been employed with GlaxoSmithKline (GSK) for 11 years, where she is currently Associate Director of Alliance, Program, and Project Management.
Novavax trials highlight Maryland’s COVID-fighting complex When Novavax Inc. received $1.6 billion last year from the federal government to speed up testing and production of a coronavirus vaccine, some observers [….]